A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™
A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™
Active, not recruiting · NCT06320535 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™ | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 1 | 2026-04-13 | NCT06320535 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bill and Melinda Gates Foundation | 67 |
| University Hospitals Bristol and Weston NHS Foundation Trust | 15 |
| University of Oxford | 213 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre for Clinical Vaccinology and Tropical Meducine, Churchill Hospital, University of Oxford | Oxford | United Kingdom | 1 |
| University Hospitals Bristol and Weston NHS Foundation Trust | Bristol | United Kingdom | 3 |